lifestyle.faithfamilyamerica.com

Author: BriaCell Therapeutics Corp.

BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer

February 17, 2026
BriaCell Patients’ Images Show Regression and Resolution of Metastasized Tumors and Immune Activation

January 28, 2026
BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients

January 27, 2026